Drugs & medicalClass III

SUN PHARMACEUTICAL INDUSTRIES INC recalls buPROPion Hydrochloride Extended-Release Tablet, USP (SR), 200 mg, 60-count bottle, Rx only Distributed by: Sun Pharmaceutical…

Presence Of Foreign Substance: Customer complaint for the presence of dark, gritty substance found within the bottle which was determined to be activated carbon from the desiccant canister inside the bottle.

Read the official notice →
Date
2022-05-18
Country
United States
Brand
Sun Pharmaceutical Industries
Product
buPROPion Hydrochloride Extended-Release Tablet, USP (SR), 200 mg, 60-count bottle, Rx only Distributed by: Sun Pharmaceutical Industries,…
Classification
Class III
Units
Nationwide in the USA
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Sun Pharmaceutical Industries recalls

  1. 2022-06-29
  2. US
    Drugs & medicalClass II

    SUN PHARMACEUTICAL INDUSTRIES INC recalls Testosterone Cypionate Injection, USP, 200 mg/mL, 1 mL Single-dose vial per carton, Rx only, Distributed by: Sun Pharmaceutical…

    Lack of Assurance of Sterility: Manufacturing deviation which was reported due to a microbial excursion

    FDA · DrugSUN PHARMACEUTICAL INDUSTRIES INCNationwide within the United StatesOfficial notice →
  3. US
    Drugs & medicalClass II

    SUN PHARMACEUTICAL INDUSTRIES INC recalls Testosterone Cypionate Injection, USP, 200 mg/mL, 1 mL Single-dose vial per carton, Rx only, Distributed by: Sun Pharmaceutical…

    CGMP Deviations: lots made with same active pharmaceutical ingredient (API) as lots that were rejected due to manufacturing issues that could cause the product to be out of specification for impurities.

    FDA · DrugSUN PHARMACEUTICAL INDUSTRIES INCNationwide in the USA and Puerto RicoOfficial notice →
  4. 2022-06-22
  5. US
  6. 2022-04-13
  7. US
    Drugs & medicalClass III

    SUN PHARMACEUTICAL INDUSTRIES INC recalls Cequa (cyclosporine ophthalmic solution) 0.09%, packaged in 6 pouches x 10 single-use vials (0.25 mL each) per box,…

    Subpotent Drug and Presence of Particulate Matter: low out-of-specification results obtained for assay and the presence of particulate matter.

    FDA · DrugSUN PHARMACEUTICAL INDUSTRIES INCNationwide in the USA.Official notice →
  8. 2022-02-23
  9. US
    Drugs & medicalClass II

    SUN PHARMACEUTICAL INDUSTRIES INC recalls Chlorthalidone Tablets USP 25 mg, Rx Only, 100 Tablets, Sun Pharma, Mfg. by: Fontida Bio Pharm Inc., 1100 Orthodox St.…

    Foreign Matter identified as stainless steel microscopic wear particles mixed with punch lubricant oil and silicone particles from the dust cup

    FDA · DrugSUN PHARMACEUTICAL INDUSTRIES INCNationwide with the United StatesOfficial notice →
  10. 2022-01-12
  11. US
    Drugs & medicalClass II

    SUN PHARMACEUTICAL INDUSTRIES INC recalls Pregabalin Capsules, 50 mg, 100 count bottle, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512,…

    Failed Tablet/Capsule Specifications: Out of Specification results for particle Size Distribution and Bulk Density of the Active Pharmaceutical Ingredient.

    FDA · DrugSUN PHARMACEUTICAL INDUSTRIES INCNationwide in the USAOfficial notice →
All 57 Sun Pharmaceutical Industries recalls →

Other drugs & medical recalls in the United States

  1. 2022-05-18
  2. US
  3. US
    Drugs & medicalClass II

    Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalls Esomeprazole Magnesium Delayed-Release Capsules, USP 20 mg, packaged in Unit Dose Blister Cards of 6 (10…

    Failed Impurities/Degradation Specifications: OOS result was obtained for Any Other Individual Impurity at the 12M room temperature time point.

    FDA · DrugMylan Institutional, Inc. (d.b.a. UDL Laboratories)Nationwide within USAOfficial notice →
  4. US
    Drugs & medicalClass II

    Lula Holdings L.L.C. recalls Kill 'Dat Sanitizing Products Hand Sanitizer, 1 gallon (128 fl. oz.) 80% Alcohol, OTC, Manufactured by: Lula Holdings LLC, 15532 St.…

    CGMP Deviations: FDA analysis found product to contain acetaldehyde above specification limits.

    FDA · DrugLula Holdings L.L.C.LAOfficial notice →
  5. US
    Drugs & medicalClass I

    Fagron, Inc recalls SyrSpend SF Suspending Base, Cherry Flavored, packaged in a) 500mL bottles (NDC 51552-1123-5) and b) 4L bottles (NDC 51552-1123-9), Rx…

    Microbial Contamination of Non-Sterile Product: Product is contaminated with Burkholderia gladioli.

    FDA · DrugFagron, IncNationwide USA and Puerto Rico, Canada, Columbia, FranceOfficial notice →
  6. US
    Drugs & medicalClass II

    Amgen, Inc. recalls MVASI (bevacizumab-awwb), Injection, For Intravenous Infusion After Dilution, 100 mg/4 ml, Single dose vial, Rx only, Manufactured by…

    Defective container: loose crimp defect, potential loss of container integrity.

    FDA · DrugAmgen, Inc.Nationwide in the USA, Egypt and Lithuania.Official notice →
  7. US
    Drugs & medicalClass II

    Viatris Inc recalls Xanax XR (alprazolam) extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Fizer…

    Failed Dissolution Specifications: low out of specification results for dissolution.

    FDA · DrugViatris IncProduct was distributed nationwide in the USAOfficial notice →
See all drugs & medical recalls →